New drug shows promise for diabetic kidney damage in Mid-Stage trial
Disease control
Completed
This study tested a new drug called CU01-1001 in 240 adults with type 2 diabetes and early kidney damage (albuminuria). Participants took the drug or a placebo for 24 weeks to see if it could reduce protein leakage in urine, a sign of kidney health. The goal is to find a treatmen…
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC